Nxera Pharma Co., Ltd. (TYO: 4565)
Japan
· Delayed Price · Currency is JPY 1,138.00
+1.00 (0.09%)
Nov 22, 2024, 11:35 AM JST
Nxera Pharma Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 102,218 | 127,103 | 175,151 | 155,210 | 145,054 | 167,282 | Upgrade
|
| Market Cap Growth | -9.84% | -27.43% | 12.85% | 7.00% | -13.29% | 174.39% | Upgrade
|
| Enterprise Value | 122,759 | 158,025 | 143,645 | 134,496 | 123,808 | 152,936 | Upgrade
|
| Last Close Price | 1137.00 | 1421.00 | 2138.00 | 1904.00 | 1800.00 | 2171.00 | Upgrade
|
| PE Ratio | - | - | 461.77 | 153.55 | 96.83 | 117.35 | Upgrade
|
| Forward PE | 40.82 | 62.51 | 62.98 | 37.67 | 87.15 | 50.84 | Upgrade
|
| PS Ratio | 3.42 | 9.96 | 11.25 | 8.76 | 16.41 | 17.20 | Upgrade
|
| PB Ratio | 1.51 | 1.90 | 3.02 | 2.70 | 2.77 | 3.71 | Upgrade
|
| P/TBV Ratio | - | - | 5.14 | 4.67 | 5.49 | 9.45 | Upgrade
|
| P/FCF Ratio | 58.68 | - | 18.10 | 22.49 | 31.67 | 52.77 | Upgrade
|
| P/OCF Ratio | 45.67 | - | 17.60 | 21.88 | 31.05 | 48.61 | Upgrade
|
| EV/Sales Ratio | 4.19 | 12.38 | 9.23 | 7.59 | 14.00 | 15.72 | Upgrade
|
| EV/EBITDA Ratio | 46.18 | - | 34.56 | 16.43 | 56.17 | 62.45 | Upgrade
|
| EV/EBIT Ratio | - | - | 51.08 | 19.46 | 144.97 | 159.31 | Upgrade
|
| EV/FCF Ratio | 70.47 | - | 14.85 | 19.49 | 27.03 | 48.24 | Upgrade
|
| Debt / Equity Ratio | 1.02 | 1.11 | 0.51 | 0.51 | 0.32 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 26.11 | - | 7.15 | 3.57 | 7.54 | 0.77 | Upgrade
|
| Debt / FCF Ratio | 39.84 | - | 3.07 | 4.24 | 3.63 | 0.59 | Upgrade
|
| Asset Turnover | 0.19 | 0.10 | 0.16 | 0.20 | 0.13 | 0.17 | Upgrade
|
| Quick Ratio | 3.73 | 3.55 | 16.90 | 8.67 | 13.96 | 8.28 | Upgrade
|
| Current Ratio | 4.01 | 3.79 | 17.09 | 8.73 | 14.08 | 8.49 | Upgrade
|
| Return on Equity (ROE) | -5.90% | -11.53% | 0.66% | 1.85% | 3.04% | 3.30% | Upgrade
|
| Return on Assets (ROA) | -0.54% | -5.07% | 1.79% | 4.98% | 0.80% | 1.04% | Upgrade
|
| Return on Capital (ROIC) | -0.61% | -5.69% | 2.02% | 5.55% | 0.92% | 1.26% | Upgrade
|
| Earnings Yield | -3.70% | -5.66% | 0.22% | 0.66% | 1.02% | 0.86% | Upgrade
|
| FCF Yield | 1.70% | -4.78% | 5.52% | 4.45% | 3.16% | 1.90% | Upgrade
|
| Buyback Yield / Dilution | -7.43% | 0.09% | -0.71% | -3.16% | -2.59% | -1.65% | Upgrade
|
| Total Shareholder Return | -7.43% | 0.09% | -0.71% | -3.16% | -2.59% | -1.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.